Impact of null genotypes of GSTT1 and GSTM1 with uterine leiomyoma risk in Iranian population

The Journal of Obstetrics and Gynaecology Research
Salva Sadat MostafaviFoozieh Javadi

Abstract

Few studies have investigated the role of the GSTM1 and GSTT1 genes in uterine leiomyoma. Therefore, in the current study the distribution of these genotypes in Iranian women and susceptibility to uterine leiomyoma was investigated. Blood samples of 50 patients with uterine leiomyoma and 50 healthy individual controls were collected in this cross-sectional study. Genomic DNA was extracted, and subsequently GSTM1 and GSTT1 null genotypes were detected by the Gap-polymerase chain reaction method. A total of 42% of patients appeared to lack GSTM1 enzyme activity due to the presence of an extended deletion (GSTM1 0/0 genotype), compared with 18% in a control group (odds ratio [OR], 3.56; 95% confidence interval [CI], 1.35-9.37; P < 0.010). In addition, the prevalence of the GSTT1 null genotype in patients was higher than that in the control group (42% to 14%, P < 0.009). Also, it was shown that individuals with both null genotypes (-/-) had a 19.23-fold higher risk of developing the disease in comparison to people who showed both present genotypes (+/+). (P = 0.007; 95%CI, 2.20-167.41). Besides, it was observed that at least one null genotype increases the risk of myoma to 2.6 compared to the both present genotype (P-value < 0.03, ...Continue Reading

References

Mar 4, 2000·Endocrine Reviews·J G Liehr
Aug 10, 2000·The Journal of Biological Chemistry·I Jaitovitch-GroismanG Batist
Aug 30, 2000·Journal of the National Cancer Institute. Monographs·J D Yager
Aug 30, 2000·Journal of the National Cancer Institute. Monographs·E CavalieriD Roy
Aug 30, 2000·Journal of the National Cancer Institute. Monographs·P A Thompson, C Ambrosone
Feb 24, 2001·Lancet·E A Stewart
Aug 5, 2004·Obstetrics and Gynecology·Edward E Wallach, Nikos F Vlahos
Mar 1, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer A DohertyChu Chen
Apr 6, 2005·Cancer Letters·Fritz F Parl
Sep 26, 2007·Human Molecular Genetics·Jennelle C Hodge, Cynthia C Morton
Oct 3, 2008·Fertility and Sterility·Emerson de OliveiraManoel João Batista Castello Girão
May 28, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Zahra HosseinzadehZiba Zahiri Sorouri
May 28, 2010·Journal of Human Genetics·Mohammad Reza SafarinejadShiva Safarinejad
May 12, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Stalo KarageorgiImmaculata De Vivo
May 12, 2012·Asian Pacific Journal of Tropical Medicine·Ying Liu, Liang-Zhi Xu
Apr 6, 2013·Fertility and Sterility·Md Soriful IslamPasquapina Ciarmela
Oct 29, 2013·Obstetrics and Gynecology International·Andrea CiavattiniPasquapina Ciarmela
Feb 19, 2014·Genetics and Molecular Research : GMR·A L OliveiraM Barbosa de Melo
Apr 22, 2014·Cell Reports·Mikko TurunenThomas G Boyer
Nov 5, 2014·Annals of Medical and Health Sciences Research·Rm MoroniLgo Brito

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.